Learn more about
Brief Product Outline and Illustration
Questions about Ovidrel® Pen ?
Call our 24/7 toll-free support line at 1-800-387-8479 or submit your questions and comments using our online form.
Overview
OVIDREL is the only recombinant human chorionic gonadotrophin (r-hCG). Its generic name is choriogonadotropin alfa. It is produced as a solution in a pre-filled syringe or a pre-filled pen that is intended for subcutaneous injection. OVIDREL ensures that you are receiving the highest purity hCG on the market. Subcutaneous injections offer the advantage of being convenient and easy to self-administer.
Feel free to pause at any time during the video. You may also advance or rewind the video by moving your cursor along the progress bar. Depending on your internet connection, it may take a few minutes for the video to load.
An Ovidrel® Pen injection guide is included in a pamphlet called Patient Instructions for the Ovidrel® Prefilled Pen, which is available for download. The guide is offered in English or French—please click on the language of your choice. Should you require injection assistance in your language of origin, please call the Momentum patient program at 1-800-387-8479.
Ovidrel® is provided at a dose of 250 μg as a liquid*:
* Note that μg stands for microgram, and mL stands for milliliter, which are units of measure
Each prefilled pen should only be used once and then thrown away.
Ovidrel® is injected at a dose of 250 μg. Your doctor will recommend the appropriate treatment regimen for you.
OVIDREL is used to trigger ovulation in patients with ovarian dysfunction. OVIDREL is indicated for women following the stimulation phase of infertility treatment.
You should not use Ovidrel® if you:
- are allergic to choriogonadotropin alpha or to any of the other ingredients of Ovidrel®
- have primary ovarianovarianrelating to an ovary or the ovaries failure
- have uncontrolled thyroidthyroida gland in the neck that secretes hormones regulating growth and development or adrenaladrenal (gland[s])adrenal (gland[s]) are small glands that sit on top of the kidneys and produce certain hormones dysfunction
- have a brain tumour in the pituitary glandpituitary glandthe gland located at the base of the brain that secretes a number of important hormones that regulate fertility, as well as normal growth and development of the body or hypothalamushypothalamusthe gland at the base of the brain that controls the release of hormones from the pituitary glands
- are pregnant
- have ovarianovarianrelating to an ovary or the ovaries cyst or enlargement of undetermined origin
- have abnormal bleeding from your uterusuterusthe womb of an unknown cause
- have ovarianovarianrelating to an ovary or the ovaries, uterineuterinerelating to the uterus (womb), or breast cancer
Please inform your doctor and pharmacist if you are taking or have taken any other medications, even those not requiring a prescription.
Contact your doctor if you experience severe pain or bloating in the stomach or pelvic area, severe upset stomach, vomiting, or weight gain, as these are symptoms of a medical event called ovarianovarianrelating to an ovary or the ovaries hyperstimulation syndrome (OHSSovarian hyperstimulation syndrome (OHSS)OHSS is caused when the ovaries become overstimulated by the various hormones that cause follicular development; there is a sudden ovarian enlargement accompanied by fluid accumulation in the abdominal cavity and this may occur with or without pain, and with or without accumulation of fluid in the lungs). OHSSovarian hyperstimulation syndrome (OHSS)OHSS is caused when the ovaries become overstimulated by the various hormones that cause follicular development; there is a sudden ovarian enlargement accompanied by fluid accumulation in the abdominal cavity and this may occur with or without pain, and with or without accumulation of fluid in the lungs occurs infrequently (usually less than 3% incidence). However, because OHSSovarian hyperstimulation syndrome (OHSS)OHSS is caused when the ovaries become overstimulated by the various hormones that cause follicular development; there is a sudden ovarian enlargement accompanied by fluid accumulation in the abdominal cavity and this may occur with or without pain, and with or without accumulation of fluid in the lungs can progress rapidly to a serious medical event, Ovidrel® should be stopped at the first signs of OHSSovarian hyperstimulation syndrome (OHSS)OHSS is caused when the ovaries become overstimulated by the various hormones that cause follicular development; there is a sudden ovarian enlargement accompanied by fluid accumulation in the abdominal cavity and this may occur with or without pain, and with or without accumulation of fluid in the lungs.
Reports of multiple births have been associated with fertility treatments. You should discuss the potential risk of multiple births with your doctor before beginning treatment.
There is no evidence to make an association between the administration of Ovidrel® to female patients and the occurrence of congenitalcongenitalpresent from birth disabilities in their children.
As with other hCGhuman chorionic gonadotropin (hCG)a hormone produced in early pregnancy (released by the placenta after implantation of a fertilized egg) that keeps the corpus luteum producing other hormones that prevent menstruation preparations, side effects can occur with the use of Ovidrel®: discomfort at the injection site, stomach pain, nausea, and vomiting have been reported. Ask your fertility team to discuss the possible side effects with you. As with all medications, it is important to report any physical changes and all symptoms to your healthcare professional.
Refer to the date indicated on the labels for the expiry date and not use the medication after expiry date. Store the medication in the original package, protected from light, and do not freeze Ovidrel®. Store the medication out of the reach of children.
Ovidrel® in prefilled pens is to be stored at 2–8°C (in a refrigerator).
Ovidrel® should not be used if the liquid contains particles or is not clear.
You should throw away the used needle safely in a sharps container.
When the pen is empty, ask your pharmacist how to dispose of it. Medicines should not be disposed of via wastewater or household waste.
You can dispose of your used Ovidrel® pens in an environmentally responsible manner by participating in the EMD Serono ecoProgram.
- What is the ecoProgram?
EMD Serono's ecoProgram will help reduce landfill by turning used Ovidrel® prefilled pens to clean energy via the Waste-to-Energy (WtE)waste-to-energy (WtE)WtE is a process where waste is burned in a controlled combustion chamber at high temperatures and reduced to 10% of its original volume (hence reducing landfill); the heat generated from the combustion chambers heats up water in steel tubes that form the walls of the combustion chambers and the water is turned to steam and sent through a turbine that continues generates electricity process. We care for patients, and our planet!
WtEwaste-to-energy (WtE)WtE is a process where waste is burned in a controlled combustion chamber at high temperatures and reduced to 10% of its original volume (hence reducing landfill); the heat generated from the combustion chambers heats up water in steel tubes that form the walls of the combustion chambers and the water is turned to steam and sent through a turbine that continues generates electricity is a process where waste (like used Ovidrel® prefilled pens) is burned in a controlled combustion chamber at high temperatures and reduced to 10% of its original volume (hence reducing landfill). The heat generated from the combustion chambers heats up water in steel tubes that form the walls of the combustion chambers. The water is turned to steam and sent through a turbine that continuously generates electricity.
According to the US Energy Recovery Council, 87 WtEwaste-to-energy (WtE)WtE is a process where waste is burned in a controlled combustion chamber at high temperatures and reduced to 10% of its original volume (hence reducing landfill); the heat generated from the combustion chambers heats up water in steel tubes that form the walls of the combustion chambers and the water is turned to steam and sent through a turbine that continues generates electricity plants divert approximately 90,000 tons of waste each day from landfills, generating nearly 17 billion kilowatt hours of electricity per year. This is enough to power almost two million homes and represents nearly 20% of all non-hydro renewable electricity generation in the United States. To put this figure into context, it would take 7.8 million tons of coal to produce the same amount of electricity from a coal-fired power plant. (Source: www.energyrecoverycouncil.org)
- How can I participate?
First, make sure your fertility clinic is participating in the Ovidrel® ecoProgram. If not, ask them to join in the cause.
Easy 3 steps:
1. Bring the used pens (without needles) back to your clinic.
2. Put pens in a reusable ecoProgram table-top container. When the container is full, simply empty them into the pre-labelled carton box provided.
3. The used pens will get sent to a WtEwaste-to-energy (WtE)WtE is a process where waste is burned in a controlled combustion chamber at high temperatures and reduced to 10% of its original volume (hence reducing landfill); the heat generated from the combustion chambers heats up water in steel tubes that form the walls of the combustion chambers and the water is turned to steam and sent through a turbine that continues generates electricity plant for processing to produce electricity.
- Ovidrel® Product Monograph. October 11, 2023. EMD Serono, A Division of EMD Inc., Canada.
OVIDREL is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.
©2023 EMD Serono, a business of Merck KGaA, Darmstadt, Germany
Questions?
Please call MOMENTUM toll free at 1-800-387-8479
